1 / 8

Case Study: Accelerating Business Performance through Strategy Enablement

Case Study: Accelerating Business Performance through Strategy Enablement. Andrew Cooper Strategy Enablement & Business Performance Global Medicines Development AstraZeneca 10 October 2012. We will look at. Some Context. AZ Corporate Strategy. AZ Business Model.

komala
Download Presentation

Case Study: Accelerating Business Performance through Strategy Enablement

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Case Study: Accelerating Business Performance through Strategy Enablement Andrew Cooper Strategy Enablement & Business Performance Global Medicines Development AstraZeneca 10 October 2012

  2. We will look at... R&D | Global Medicines Development

  3. Some Context... AZ Corporate Strategy AZ Business Model Global Medicines Development Operational Span R&D | Global Medicines Development

  4. Strategy Enablement and Business Performance R&D | Global Medicines Development

  5. What does this mean in practice? Some examples of what we deliver .... ...with 5 Business Partners working within and across Global Medicines Development Leadership Teams R&D | Global Medicines Development

  6. Evolution to Business Partnering... Business Partnering delivers more value ...progressing through the Business Partnering maturity.... ... by applying the Service Delivery Model.... Understand what Business Partnering is.... • Business Partnering encompasses the high value services focused on decision support, which high performing functions deliver to the broader business in order to manage risk, drive enterprise performance & hold managers to account for performance. • Business partnering is typically associated with the capability to drive optimal management decisions and challenge the decision makers, in order to drive performance consistently with the strategic intent of the enterprise Reproduced with the permission of The Hackett Group www.thehackettgroup.com R&D | Global Medicines Development

  7. External Best Practice Business Management Office “Helping with the process of strategy, helping with the information that supports the strategy process, providing creative facilitation, providing various tools to help make decisions, and being able to gather the information that helps make a good decision” • Business Management should encompass the high value services that are focused on decision support, which high performing functions then deliver to the broader business in order to manage risk, drive enterprise performance & hold managers to account for performance. • Business managing is typically associated with the capability to drive optimal management decisions and challenge the decision makers, in order to drive performance consistently with the strategic intent of the enterprise. • Key success factors include the ability to increase business effectiveness through a focus on strategic projects and enhancing the capabilities required to deliver. • Effective business management/internal consultancy groups have a clearly defined identity, experience strong senior sponsorship and are effective at demonstrating their value add to the wider business. • Centralization of these services appears to be the preferred model due to efficiencies and cost savings, the majority of groups comprising 15-20 individuals. There is a belief that smaller groups may be too resource constrained to be effective. • This Business Management/Internal Consultancy model has been adopted by a growing number of organisations: BASF, Rolls Royce, Fidelity Investments, Cargill, Chevron, ExxonMobil, Pfizer, Statoil, DELL, AstraZeneca… R&D | Global Medicines Development

  8. Confidentiality Notice This file is private and may contain confidential and proprietary information. If you have received this file in error, please notify us and remove it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorized use or disclosure of the contents of this file is not permitted and may be unlawful. AstraZeneca PLC, 2 Kingdom Street, London, W2 6BD, UK, T: +44(0)20 7604 8000, F: +44 (0)20 7604 8151, www.astrazeneca.com Set area descriptor | Sub level 1

More Related